Record fourth quarter sales and earnings helped Fischer Imagingfinish its 1995 fiscal year with a flourish. The Denver-based x-ray vendor reported fourth-quarter earnings(end-December) of $1.5 million and $23 million in sales, bothcompany records.
Record fourth quarter sales and earnings helped Fischer Imagingfinish its 1995 fiscal year with a flourish.
The Denver-based x-ray vendor reported fourth-quarter earnings(end-December) of $1.5 million and $23 million in sales, bothcompany records. Revenues were up 25% from the same period of1994.
For the 1995 fiscal year, Fischer reported net earnings of$2.3 million on the strength of $76.8 million in sales. The performancewas a notable improvement over fiscal 1994, when the company lost$5.6 million on sales of $68.5 million. CEO Morgan Nields attributedthe turnaround to an improved sales mix and global sales growth,as well as gains made through OEM deals and internal cost-cuttingmeasures.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.